NCT01437943View on ClinicalTrials.gov

Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients

PHASE4TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Kidney DiseaseKidney Failure, Chronic
Interventions
DRUG

Aliskiren

Take 1 tablet (150 mg) by mouth daily for 180 days

DRUG

Placebo

Take 1 tablet (0 mg) daily for 180 days.

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Brigham and Women's Hospital

OTHER

NCT01437943 - Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients | Biotech Hunter | Biotech Hunter